Emerging diagnostic and treatment approaches in organ and stem cell transplantation
器官和干细胞移植的新兴诊断和治疗方法
基本信息
- 批准号:G0600698/1
- 负责人:
- 金额:$ 268.75万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2007
- 资助国家:英国
- 起止时间:2007 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Replacement of diseased organs and cells by healthy tissue is a dream that has partly been realised through progress in transplantation over the last 50 years. However, for transplantation therapy to achieve greater success and on a wider scale, advance is needed in several directions. These include finding supplementary sources of donor tissues and cells that lend themselves for therapy of a larger number of conditions, such as kidney and liver failure, arthritis, diabetes and tooth loss; and a way of ensuring acceptance of the replacement tissue without the need for lifelong drugs that block the immune system. To accelerate progress, experts in basic biology and transplant medicine at King s College London plan to come together in a joint venture with the Medical Research Council, to form the UK s first MRC Centre for Translation of Research in Transplantation. The Centre s mission is to put research in transplantation on a new trajectory to deliver more rapid and effective modes of diagnosis and treatment. The programme of research will apply extensive knowledge of human immunology, stem cell biology, genomics and imaging to develop new areas that will benefit human health. In collaboration with the King s College Centre of Medical Law and Ethics, the MRC Centre will also play a pivotal role in training and education.
用健康的组织替换患病的器官和细胞是一个梦想,这一梦想在一定程度上是通过过去50年来移植技术的进步实现的。然而,为了在更大的范围内取得更大的成功,移植治疗需要在几个方向上取得进展。这些措施包括寻找供体组织和细胞的补充来源,以便治疗更多的疾病,如肾功能衰竭和肝功能衰竭、关节炎、糖尿病和牙齿脱落;以及一种确保替代组织被接受的方法,而不需要终生阻断免疫系统的药物。为了加快进展,伦敦S国王学院的基础生物学和移植医学专家计划与医学研究理事会成立一家合资企业,成立英国S首个移植研究翻译中心。S中心的使命是将移植研究推向新的轨道,提供更快速有效的诊断和治疗模式。该研究计划将应用人类免疫学、干细胞生物学、基因组学和成像的广泛知识,以开发有利于人类健康的新领域。医疗资源中心还将与S国王学院医学法和医德中心合作,在培训和教育方面发挥关键作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven Sacks其他文献
Lets connect: A novel role for CD46 in tight junction regulation
- DOI:
10.1016/j.molimm.2010.05.166 - 发表时间:
2010-08-01 - 期刊:
- 影响因子:
- 作者:
Samia Al-Shouli;John Cardone;Steven Sacks;Claudia Kemper - 通讯作者:
Claudia Kemper
Response of caudal neurosecretory cells of Salvelinus fontinalis to variations in the ionic composition of the environment
- DOI:
10.1007/bf00215148 - 发表时间:
1984-09-01 - 期刊:
- 影响因子:2.900
- 作者:
Steven Sacks;Gaston Chevalier - 通讯作者:
Gaston Chevalier
Steven Sacks的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven Sacks', 18)}}的其他基金
Efficacy of Mirococept (APT070) for Preventing Ischaemia-Reperfusion Injury associated with Kidney Transplantation-2 (EMPIRIKAL-2)
Mirococept (APT070) 预防肾移植相关缺血再灌注损伤的功效-2 (EMPIRIKAL-2)
- 批准号:
MR/V038281/1 - 财政年份:2022
- 资助金额:
$ 268.75万 - 项目类别:
Research Grant
Measuring the impact of monoclonal antibody drugs in cancer and rheumatoid arthritis
测量单克隆抗体药物对癌症和类风湿性关节炎的影响
- 批准号:
MC_PC_20057 - 财政年份:2021
- 资助金额:
$ 268.75万 - 项目类别:
Intramural
Characterisation of glycan ligands recognised by collectin-11 in ischaemic kidney and development of a specific antagonistic probe
缺血肾中collectin-11识别的聚糖配体的表征以及特异性拮抗探针的开发
- 批准号:
MR/R010757/1 - 财政年份:2018
- 资助金额:
$ 268.75万 - 项目类别:
Research Grant
Collectin-11 as a trigger of the innate immune response in renal transplantation
Collectin-11 作为肾移植中先天免疫反应的触发因素
- 批准号:
MR/M012263/1 - 财政年份:2015
- 资助金额:
$ 268.75万 - 项目类别:
Research Grant
Development Clinical Studies - investigation into the efficacy of Mirococept in renal transplantation
开发临床研究-Mirococept在肾移植中的疗效调查
- 批准号:
G1001197/1 - 财政年份:2011
- 资助金额:
$ 268.75万 - 项目类别:
Research Grant
Targeting the complement system in transplantation
移植中针对补体系统
- 批准号:
G0600892/1 - 财政年份:2007
- 资助金额:
$ 268.75万 - 项目类别:
Research Grant
相似国自然基金
OBSL1功能缺失导致多指(趾)畸形的分子机制及其临床诊断价值
- 批准号:82372328
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
HER2特异性双抗原表位识别诊疗一体化探针研制与临床前诊疗效能研究
- 批准号:82372014
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
相似海外基金
Epidemiology and determinants of emerging artemisinin-resistant malaria in Ethiopia
埃塞俄比亚新出现的青蒿素耐药性疟疾的流行病学和决定因素
- 批准号:
10718838 - 财政年份:2023
- 资助金额:
$ 268.75万 - 项目类别:
Neural and behavioral correlates of deliberate emotion regulation in early childhood: testing unique links to emerging irritability
幼儿期刻意情绪调节的神经和行为相关性:测试与新出现的烦躁的独特联系
- 批准号:
10570643 - 财政年份:2022
- 资助金额:
$ 268.75万 - 项目类别:
West African Emerging Infectious Disease Research Center (WA-EIDRC)
西非新发传染病研究中心 (WA-EIDRC)
- 批准号:
10653441 - 财政年份:2022
- 资助金额:
$ 268.75万 - 项目类别:
Multi-center Evaluation of the Threat of Established and Emerging Respiratory Viral Infections in Pediatric Transplant Recipients
儿科移植受者中已发生和新出现的呼吸道病毒感染威胁的多中心评估
- 批准号:
10490914 - 财政年份:2021
- 资助金额:
$ 268.75万 - 项目类别:
Temperodynamic neural variability as an early-emerging biomarker of autism spectrum disorders
温度动力学神经变异作为自闭症谱系障碍的早期生物标志物
- 批准号:
10487546 - 财政年份:2021
- 资助金额:
$ 268.75万 - 项目类别:
Temperodynamic neural variability as an early-emerging biomarker of autism spectrum disorders
温度动力学神经变异作为自闭症谱系障碍的早期生物标志物
- 批准号:
10369417 - 财政年份:2021
- 资助金额:
$ 268.75万 - 项目类别:
Multi-center evaluation of the threat of established and emerging respiratory viral infections in pediatric transplant recipients
对儿科移植受者中已发生和新出现的呼吸道病毒感染威胁的多中心评估
- 批准号:
10367953 - 财政年份:2021
- 资助金额:
$ 268.75万 - 项目类别:
Multi-center Evaluation of the Threat of Established and Emerging Respiratory Viral Infections in Pediatric Transplant Recipients
儿科移植受者中已发生和新出现的呼吸道病毒感染威胁的多中心评估
- 批准号:
10685416 - 财政年份:2021
- 资助金额:
$ 268.75万 - 项目类别:
Temperodynamic neural variability as an early-emerging biomarker of autism spectrum disorders
温度动力学神经变异作为自闭症谱系障碍的早期生物标志物
- 批准号:
10687865 - 财政年份:2021
- 资助金额:
$ 268.75万 - 项目类别:
Emerging Diffuse Optical Imaging Technologies for Precision Medicine
用于精准医疗的新兴漫射光学成像技术
- 批准号:
10669234 - 财政年份:2021
- 资助金额:
$ 268.75万 - 项目类别: